Literature DB >> 35916724

Selective disruption of Drp1-independent mitophagy and mitolysosome trafficking by an Alzheimer's disease relevant tau modification in a novel Caenorhabditis elegans model.

Sanjib Guha1, Anson Cheng1, Trae Carroll2, Dennisha King3, Shon A Koren1, Sierra Swords4, Keith Nehrke5, Gail V W Johnson1.   

Abstract

Accumulation of inappropriately phosphorylated tau into neurofibrillary tangles is a defining feature of Alzheimer's disease, with Tau pT231 being an early harbinger of tau pathology. Previously, we demonstrated that expressing a single genomic copy of human phosphomimetic mutant tau (T231E) in Caenorhabditis elegans drove age-dependent neurodegeneration. A critical finding was that T231E, unlike wild-type tau, completely and selectively suppressed oxidative stress-induced mitophagy. Here, we used dynamic imaging approaches to analyze T231E-associated changes in mitochondria and mitolysosome morphology, abundance, trafficking, and stress-induced mitophagy as a function of mitochondrial fission mediator dynamin-related protein 1, which has been demonstrated to interact with hyper phosphorylated tau and contribute to Alzheimer's disease pathogenesis, as well as Pink1, a well-recognized mediator of mitochondrial quality control that works together with Parkin to support stress-induced mitophagy. T231E impacted both mitophagy and mitolysosome neurite trafficking with exquisite selectivity, sparing macroautophagy as well as lysosome and autolysosome trafficking. Both oxidative-stress-induced mitophagy and the ability of T231E to suppress it were independent of drp-1, but at least partially dependent on pink-1. Organelle trafficking was more complicated, with drp-1 and pink-1 mutants exerting independent effects, but generally supported the idea that the mitophagy phenotype is of greater physiologic impact in T231E. Collectively, our results refine the mechanistic pathway through which T231E causes neurodegeneration, demonstrating pathologic selectivity for mutations that mimic tauopathy-associated post-translational modifications, physiologic selectivity for organelles that contain damaged mitochondria, and molecular selectivity for dynamin-related protein 1-independent, Pink1-dependent, perhaps adaptive, and mitophagy.
© The Author(s) 2022. Published by Oxford University Press on behalf of Genetics Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Caenorhabditis eleganszzm321990 ; Alzheimer’s disease; Drp1; Pink1; mitochondria; mitophagy; tau phosphorylation

Mesh:

Substances:

Year:  2022        PMID: 35916724      PMCID: PMC9434186          DOI: 10.1093/genetics/iyac104

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.402


  139 in total

1.  Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.

Authors:  A Sengupta; J Kabat; M Novak; Q Wu; I Grundke-Iqbal; K Iqbal
Journal:  Arch Biochem Biophys       Date:  1998-09-15       Impact factor: 4.013

2.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

3.  Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study.

Authors:  Ralph A Nixon; Jerzy Wegiel; Asok Kumar; Wai Haung Yu; Corrinne Peterhoff; Anne Cataldo; Ana Maria Cuervo
Journal:  J Neuropathol Exp Neurol       Date:  2005-02       Impact factor: 3.685

4.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.

Authors:  Brian C Kraemer; Bin Zhang; James B Leverenz; James H Thomas; John Q Trojanowski; Gerard D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-18       Impact factor: 11.205

5.  Autophagy compensates for defects in mitochondrial dynamics.

Authors:  Simon Haeussler; Fabian Köhler; Michael Witting; Madeleine F Premm; Stéphane G Rolland; Christian Fischer; Laetitia Chauve; Olivia Casanueva; Barbara Conradt
Journal:  PLoS Genet       Date:  2020-03-19       Impact factor: 5.917

6.  Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading.

Authors:  Yin Xu; Nicholas E Propson; Shuqi Du; Wen Xiong; Hui Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 12.779

Review 7.  Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.

Authors:  P Hemachandra Reddy; Darryll Ma Oliver
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

8.  Disease-associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria.

Authors:  Nadia Cummins; Andrea Tweedie; Steven Zuryn; Jesus Bertran-Gonzalez; Jürgen Götz
Journal:  EMBO J       Date:  2018-12-11       Impact factor: 11.598

9.  Severe oligomeric tau toxicity can be reversed without long-term sequelae.

Authors:  Alfonso Martinisi; Martin Flach; Frederik Sprenger; Stephan Frank; Markus Tolnay; David T Winkler
Journal:  Brain       Date:  2021-04-12       Impact factor: 13.501

Review 10.  Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease.

Authors:  Amy F T Arnsten; Dibyadeep Datta; Kelly Del Tredici; Heiko Braak
Journal:  Alzheimers Dement       Date:  2020-10-19       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.